cyclophosphamide,rapcabtagene autoleucel,fludarabine,ytb323
novartis,novartis,Bayer
['fil,veral,12', 'fludarabine', 'rapcabtagene', 'cyclophosphamide', 'ytb323', 'dlbcl']
congress | #ash22 discussed use of rapcabtagene autoleucel at 4 dose levels, from the first in-human phase i study. a dose of 12.5 10^6 car-t cells was chosen as the recommended dose for phase iii studies due to response rates (73% of pts achieving cr) + safety profile. 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm